{"id":460116,"date":"2026-02-01T00:03:00","date_gmt":"2026-01-31T23:03:00","guid":{"rendered":"https:\/\/medizinonline.com\/opening-up-new-horizons-through-combination-therapies\/"},"modified":"2026-01-31T23:26:46","modified_gmt":"2026-01-31T22:26:46","slug":"opening-up-new-horizons-through-combination-therapies","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/opening-up-new-horizons-through-combination-therapies\/","title":{"rendered":"Opening up new horizons through combination therapies"},"content":{"rendered":"\n

This year’s congress of the European Society for Medical Oncology <\/em>, which took place in Berlin from October 17 to 21, 2025, offered an impressive variety of topics on numerous tumor entities and therapeutic approaches. These were presented in various formats. These included interactive formats such as the “Challenge your Expert” sessions, in which the audience could ask questions, make critical comments and confront the experts with practical challenges. In the “Challenge your Expert-Session-Gynae-Cancers”, David M. Gershenson presented new therapeutic approaches for low-grade serous ovarian cancer (LGSOC). His presentation focused on the development of innovative combination therapies that go beyond the current standards of chemotherapy and hormone therapy and open up new horizons for the treatment of this rare tumor entity. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

This year’s congress of the European Society for Medical Oncology , which took place in Berlin from October 17 to 21, 2025, offered an impressive variety of topics on numerous……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":460121,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Low grade serous ovarian carcinoma (LGSOC) ","footnotes":"[{\"id\":\"46876782-286c-41fd-8c90-a1b266efa121\",\"content\":\"According to the current WHO classification, borderline ovarian tumors (also known as tumors with low malignant potential, LMP) are epithelial ovarian tumors that morphologically lie between benign cystadenomas and invasive carcinomas. They are characterized by epithelial atypia and proliferation, but no destructive stromal invasion [3]. These tumors usually occur in younger patients aged 40 to 55 years, have a significantly better prognosis than invasive carcinomas and in individual cases can be considered a precursor lesion for low-grade serous ovarian carcinoma (LGSOC), as Kurman and Shih explain in their fundamental work on the pathogenesis of epithelial ovarian carcinomas [4]. \"}]"},"category":[11513,11400,11370,11548,11503],"tags":[13646,87993,25972,87995,88003,87988,22957,87992,20792,87990,88001,87986,87999,38712],"powerkit_post_featured":[],"class_list":["post-460116","post","type-post","status-publish","format-standard","has-post-thumbnail","category-congress-reports","category-gynecology","category-oncology","category-rx-en","category-studies","tag-braf-en","tag-chemotherapy-letrozole-versus-letrozole","tag-combination-therapy","tag-hormonal-therapy","tag-international-phase-ii-iii-study-gog-0281","tag-johns-hopkins-study","tag-kras-en","tag-low-grade-serous-ovarian-carcinoma-lgsoc","tag-maintenance-therapy","tag-map-kinase-signaling-pathway-mutation","tag-md-anderson-cancer-center-mdacc","tag-mixed-tumors-lgsoc-and-hgsoc","tag-molecular-precision-medicine","tag-nras-en","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-25 19:05:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":460114,"slug":"ouvrir-de-nouveaux-horizons-grace-aux-therapies-combinees","post_title":"Ouvrir de nouveaux horizons gr\u00e2ce aux th\u00e9rapies combin\u00e9es","href":"https:\/\/medizinonline.com\/fr\/ouvrir-de-nouveaux-horizons-grace-aux-therapies-combinees\/"},"it_IT":{"locale":"it_IT","id":460117,"slug":"aprire-nuovi-orizzonti-attraverso-le-terapie-di-combinazione","post_title":"Aprire nuovi orizzonti attraverso le terapie di combinazione","href":"https:\/\/medizinonline.com\/it\/aprire-nuovi-orizzonti-attraverso-le-terapie-di-combinazione\/"},"pt_PT":{"locale":"pt_PT","id":460120,"slug":"abrir-novos-horizontes-atraves-de-terapias-combinadas","post_title":"Abrir novos horizontes atrav\u00e9s de terapias combinadas","href":"https:\/\/medizinonline.com\/pt-pt\/abrir-novos-horizontes-atraves-de-terapias-combinadas\/"},"es_ES":{"locale":"es_ES","id":460123,"slug":"abrir-nuevos-horizontes-mediante-terapias-combinadas","post_title":"Abrir nuevos horizontes mediante terapias combinadas","href":"https:\/\/medizinonline.com\/es\/abrir-nuevos-horizontes-mediante-terapias-combinadas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/460116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=460116"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/460116\/revisions"}],"predecessor-version":[{"id":460122,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/460116\/revisions\/460122"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/460121"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=460116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=460116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=460116"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=460116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}